View More View Less
  • 1 Saveetha Institute of Medical and Technical Sciences (SIMATS), India
  • | 2 Saveetha Institute of Medical and Technical Sciences (SIMATS), India
  • | 3 Centre for Cellular and Molecular Biology, India
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Carbapenems are administered as the final drug of choice for treating complicated nosocomial infections caused by multidrug-resistant Acinetobacter baumannii strains. It is currently a worldwide issue that metallo-β-lactamases (MBLs) as carbapenem-hydrolyzing enzymes are one of the major drug resistance mechanisms. This investigation is thus aimed to assess the prevalence and characterize the MBL-producing strains of A. baumannii both by phenotypic assays and by genotypic characterization. A total of 73 isolates of A. baumannii were phenotypically and genotypically characterized from patients (N = 1,000) with severe urinary tract infection. Tested strains were subjected to double disc synergy testing (DDST) by Kirby–Bauer disc diffusion method with imipenem (IMP) and IMP/EDTA combination discs. Plasmid DNA was molecularly screened for MBL-encoding blaIMP, blaVIM, blaGIM, and blaNDM genes by PCR for the genetic relatedness of the MBL genes with carbapenem resistance. Carbapenem resistance profile showed 100%, 45%, and 49% non-susceptibility against imipenem, doripenem, and meropenem, respectively. Altogether 42.46% (n = 31) of the isolates showed MBL production upon double disc phenotypic test with IMP and IMP/EDTA discs. The blaVIM and blaGIM were detected in 34.24% (n = 25) and 16.43% (n = 12) of the isolates, respectively, while the co-occurrence of blaVIM and blaGIM was 2.73% among the isolates. DDST-positive isolates showed 21.19% and 9.58% strains positive for blaVIM and blaGIM, respectively, whereas 1.36% of the strains for both genes. None of the strains yielded blaIMP and blaNDM genes. The findings of this study showed prevalence of carbapenem resistance among A. baumannii from urine samples and the frequency of blaVIMand blaGIM.

  • 1.

    Bergogne-Berezin, E. B., Towner, K. J.: Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148165 (1996).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., Bartlett, J. G.: Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42, 657668 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Poirel, L., Nordmann, P.: Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin Microbiol Infect 12, 826836 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Richet, H. M., Mohammed, J., McDonald, L. C.: Building communication networks: International network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 7, 319322 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Ehlers, M. M., Hughes, J. M., Kock, M. M.: Prevalence of carbapenemase resistance in Acinetobacter baumannii. In Pana, M. (ed): Antibiotic Resistant Bacteria – A Continuous Challenge in The New Millennium. Intech Open, Europe, 2012, pp. 213246.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Heritier, C., Poirel, L., Lambert, T., Nordmann, P.: Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 49, 31983202 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Liakopoulos, A., Mavroidi, A., Katsifas, E., Theodosiou, A., Karagouni, A. D., Miriagou, V.: Carbapenemase-producing Pseudomonas aeruginosa from central Greece: Molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis 13, 505 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Rizek, C., Fu, L., Dos Santos, L. C., Leite, G., Ramos, J., Rossi, F., Guimaraes, T., Levin, A. S., Figueiredo Costa, S.: Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance. Ann Clin Microbiol Antimicrob 13, 43 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Schlesinger, S. R., Lahousse, M. J., Foster, T. O., Kim, S. K.: Metallo-β-lactamases and aptamer-based inhibition. Pharmaceuticals 4, 419428 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Noori, M., Karimi, A., Fallah, F.: High prevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Arch Pediat Infect Dis 2, e15439 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    King, D., Strynadka, N.: Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance. Protein Sci 20, 14841491 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Walsh, T. R., Toleman, M. A., Poirel, L., Nordmann, P.: Metallo-beta-lactamases: The quiet before the storm. Clin Microbiol Rev 18, 306325 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Amudhan, M. S., Sekar, U., Kamalanathan, A., Balaraman, S.: blaIMP and blaVIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infec Dev Ctries 6, 757762 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Cornaglia, G., Giamarellou, H., Rossolini, G. M.: Metallo-β-lactamases: A last frontier for β-lactams? Lancet Infect Dis 4, 381393 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Jones, R. N., Biedenbach, D. J., Sader, H. S., Fritsche, T. R., Toleman, M. A., Walsh, T. R.: Emerging epidemic of metallo-beta-lactamase mediated resistances. Diagn Microbiol Infect Dis 51, 7784 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Lee, K., Yum, J. H., Yong, D., Lee, M., Kim, H. D., Docquier, J. D., Rossolini, G. M., Chong, Y.: Novel acquired metallo-beta-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49, 44854491 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Göttig, S., Pfeifer, Y., Wichelhaus, T. A., Zacharowski, K., Bingold, T., Averhoff, B., Brandt, C., Kempf, V. A.: Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 10, 828829 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Kaase, M., Nordmann, P., Wichelhaus, T. A., Gatermann, S. G., Bonnin, R. A., Poirel, L.: NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 66, 12601262 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Lee, K., Lim, Y. S., Yong, D., Yum, H., Chong, Y.: Evaluation of the Hodge test and the imipenem-EDTA double disk synergy test for differentiating metallo-β-lactamase producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41, 46234629 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Srinivasan, V. B., Rajamohan, G., Pancholi, P., Stevenson, K., Tadesse, D., Patchanee, P., Marcon, M., Gebreyes, W. A.: Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA Gebreyes. Ann Clin Microbiol Antimicrob 8, 21 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Clinical Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. Table 3A: M02-A12 and M07-A10. CLSI, Wayne, PA, 2012.

    • Search Google Scholar
    • Export Citation
  • 22.

    Maleki, M. H., Sekawi, Z., Soroush, S., Azizi-Jalilian, F., Asadollahi, K. H., Mahammadi, S., Emaneini, M., Taherikalani, M.: Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran J Basic Med Sci 17, 2126 (2014).

    • Search Google Scholar
    • Export Citation
  • 23.

    Singla, P., Sikka, R., Deep, A., Chaudhary, U.: Phenotypic detection and prevalence of MBLs in carbapenem resistant isolates of Acinetobacter species at a tertiary care hospital in North India. Int J Pharma Med Bio Sci 2, 22785221 (2013).

    • Search Google Scholar
    • Export Citation
  • 24.

    Anwar, M., Ejaz, H., Zafar, A., Hamid, H.: Phenotypic detection of metallo-beta-lactamases in carbapenem resistant Acinetobacter baumannii isolated from pediatric patients in Pakistan. J Pathog 2016, 8603964 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Kabbaj, H., Seffar, M., Belefquih, B.: Prevalence of metallo-β-lactamases producing Acinetobacter baumannii in a Moroccan hospital. ISRN Infect Dis 2013, 154921 (2013).

    • Search Google Scholar
    • Export Citation
  • 26.

    Khorsi, K., Messai, Y., Hamidi, M., Ammari, H., Bakour, R.: High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac J Trop Med 8, 438446 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Uma Karthika, R., Srinivasa Rao, R., Sahoo, S., Shashikala, P., Kanungo, R., Jayachandran, S., Prashanth, K.: Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol 58, 430435 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Hussein, H. N., Al-Mathkhury, J. F. H., Sabbah, A. M.: Imipenem resistant Acinetobacter baumannii isolated from patients and hospitals environment in Baghdad. Iraq J Sci 54, 803812 (2013).

    • Search Google Scholar
    • Export Citation
  • 29.

    Daef, E. A., Mohamed, I. S., Ahmed, A. S., El-Gendy, S. G., Sayed, I. M.: Detection of outbreak caused by multidrug resistant Acinetobacter baumannii in Assiut University hospitals. Afr J Microbiol Res 8, 22382244 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Taneja, N., Maharwal, S., Sharma, M.: Imipenem resistance in non-fermenters causing nosocomial urinary tract infections. Indian J Med Sci 57, 294299 (2003).

    • Search Google Scholar
    • Export Citation
  • 31.

    Sinha, M., Srinivasa, H.: Mechanisms of resistance to carbapenems in meropenem resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol 25, 121125 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Terzi, H. A., Atasoy, A. R., Aykan, S. B., Karakece, E., Asik, G., Ciftci, H. I.: Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates. Saudi Med J 37, 4347 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Esterly, J. S., Qi, C., Malczynski, M., Scheetz, M. H.: Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and blaOXA gene status. Pharmacotherapy 30, 354360 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Goyal, K., Gautam, V., Ray, P.: Doripenem vs meropenem against Pseudomonas and Acinetobacter. Indian J Med Microbiol 30, 350351 (2012).

  • 35.

    Sousa, D., Castelo-Corral, L., Gutiérrez-Urbón, J. M., Molina, F., López-Calviño, B., Bou, G., Llinares, P.: Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: Collateral damage or positive effect on hospital ecology? J Antimicrob Chemother 68, 19171925 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Da Silva, G. J., Correia, M., Vita, C., Ribeiro, G., Sousa, J. C., Leitao, R., Peixe, L., Duarte, A.: Molecular characterization of blaIMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett 215, 3339 (2002).

    • Search Google Scholar
    • Export Citation
  • 37.

    Ellington, M. J., Kistler, J., Livermore, D. M., Woodford, N.: Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59, 321322 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Seward, R. J.: Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin Microbiol Infect 5, 308318 (1999).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Gallego, L., Towner, K. J.: Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 50, 7177 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Gupta, V., Datta, P., Chander, J.: Prevalence of metallo-β-lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect 52, 311314 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Limansky, A. S., Mussi, M. A., Viale, A. M.: Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol 40, 47764778 (2002).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., Livermore, D. M., Abbasi, S. A., Raza, M. W.: Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 66, 22882294 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    D’Andrea, M. M., Venturelli, C., Giani, T., Arena, F., Conte, V., Bresciani, P., Rumpianesi, F., Pantosti, A., Narni, F., Rossolini, G. M.: Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: Report on the first Italian cases. J Clin Microbiol 49, 27552758 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Fallah, F., Noori, M., Hashemi, A., Goudarzi, H., Karimi, A., Erfanimanesh, S., Alimehr, S.: Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica 2014, 245162 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Joshi, P. R., Acharya, M., Kakshapati, T., Leungtongkam, U., Thummeepak, R., Sitthisak, S.: Co-existence of blaOXA23 and blaNDM1 genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control 6, 21 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Lee, J. H., Choi, C. H., Kang, H. Y., Lee, J. Y., Kim, J., Lee, Y. C., Seol, S. Y., Cho, D. T., Kim, K. W., Song, D. Y., Lee, J. C.: Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 59, 633639 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 32 0 0
Mar 2021 46 0 0
Apr 2021 19 0 0
May 2021 18 0 0
Jun 2021 21 0 0
Jul 2021 68 0 0
Aug 2021 0 0 0